Bank of the Ozarks Inc. (OZRK) Drops 6.84% on January 25

Equities Staff  |

Bank of the Ozarks Inc. (OZRK) was one of the Russell 2000's biggest losers for Monday January 25 as the stock slid 6.84% to $40.72, a loss of $-2.99 per share. Starting at an opening price of $43.61 a share, the stock traded between $40.72 and $43.83 over the course of the trading day. Volume was 1.15 million shares over 11,021 trades, against an average daily volume of 836,303 shares and a total float of 88.27 million.

The losses send Bank of the Ozarks Inc. down to a market cap of $3.59 billion. In the last year, Bank of the Ozarks Inc. has traded between $54.96 and $32.42, and its 50-day SMA is currently $50.13 and 200-day SMA is $45.43.

The stock has a P/E Ratio of 21.1.

Bank of the Ozarks Inc provides retail and commercial banking services. It also provides mortgage lending, corporate cash management services, including wholesale lock box services, remote deposit capture services.

Bank of the Ozarks Inc. is based out of Little Rock, AR and has some 1,654 employees. Its CEO is George Gleason.

For a complete fundamental analysis analysis of Bank of the Ozarks Inc., check out’s Stock Valuation Analysis report for OZRK. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth


Nxt-ID Inc provides products, solutions, and services that have a need for biometric secure access control. Its lines of business include mobile commerce; law enforcement and biometric access control applications…